Search Results 651-660 of 18110 for monoclonal antibody
Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or ...
Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
Risankizumab (RZB) is a humanized monoclonal immunoglobulin antibody that selectively inhibits IL-23. Multiple phase 3 clinical trials have demonstrated ...
A monoclonal antibody is a type of protein that can bind to certain targets ... Immunotherapy with monoclonal antibodies, such as teclistamab, may help ...
Monoclonal antibodies, such as blinatumomab, may block cancer growth in different ways by targeting certain cells. It is not yet known whether combination ...
UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody ... Immunotherapy with monoclonal antibodies, such as durvalumab, may help the ...
Mayo Clinic is exploring the potential benefit of inebilizumab, a monoclonal antibody recently approved for the treatment of neuromyelitis optica spectrum ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...
Most people start therapy that contains daratumumab (Darzalex), which is a monoclonal antibody used to treat multiple myeloma. ATTR therapies. Drugs such as ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. ... Dinutuximab is a monoclonal antibody that binds to a molecule called GD2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.